Compare Milestone Pharmaceuticals vs QPS
Customers evaluate the quality of Milestone Pharmaceuticals's products using the following success metrics.
Overview
Milestone Pharmaceuticals is 21 yrs old and is based in Canada.
Milestone Pharmaceuticals (Nasdaq: MIST) is a Phase 3 clinical-stage biopharmaceutical company dedicated to developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. Etripamil is a potent and short-acting calcium channel blocker designed by Milestone and being developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of PSVT as they occur.
QPS is 29 yrs old and is based in United States.
QPS is a GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, preclinical, and clinical drug development services. Focused on bioanalytics and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction and turnkey laboratories and facilities.
Demo Video
Investors
Fonds de Solidarite FTQ, Go Capital
First Analysis and Delaware Technology Park
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Milestone Pharmaceuticals has not claimed their profile.
Work for Milestone Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Milestone Pharmaceuticals?
Claim your profile now.
Information not available because QPS has not claimed their profile.
Work for QPS? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for QPS?
Claim your profile now.